A four-year-old boy in
Doctors at
The new insulin pump system has been developed by specialist team at PMH as well as a network of hospitals across
"The technology mimics the biological function of the pancreas to predict low glucose levels and stop insulin delivery,"
"This in turn avoids the serious consequences of low glucose such as coma, seizure and potential death," it said.
Hames was diagnosed with diabetes when he was just 22 months old.
He has been receiving regular treatment at PMH since his diagnosis and will be the first child, outside of the clinical trials, to use the new device, the department said.
Xavier's mother Naomi said that the pump system was a breakthrough in Xavier's care and for others suffering with the disease worldwide.
Dr Dorota Pawlak, the Director of the JDRF Australian Type 1 Diabetes Clinical Research Network said artificial pancreas systems can transform the lives of people with Type 1 diabetes by eliminating much of the burden of the daily management of the disease while improving glucose control.
PTI